Skip to main content
SpringerLink
Log in

Rofecoxib interaction with oral anticoagulant acenocoumarol

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schwartz JI, Bugianesi KJ, Ebel DL, De Smet M, Haesen R, Larson PJ, Ko A, Verbesselt R, Hunt TL, Lins R, Lens S, Porras AG, Dieck J, Keymeulen B, Gertz BJ (2000) The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin. Clin Pharmacol Ther 68:626–636

    Google Scholar 

  2. Hermans JJ, Thijssen HH (1993) Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics. Br J Pharmacol 110:482–490

    Google Scholar 

  3. Thijssen HH, Flinois JP, Beaune PH (2000) Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes. Drug Metab Dispos 28:1284–1290

    Google Scholar 

  4. Verstuyft C, Morin S, Robert A, Loriot MA, Beaune P, Jaillon P, Becquemont L (2001) Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers. Pharmacogenetics 11:735–737

    Google Scholar 

  5. Aithal GP, Day CP, Kesteven PJ, Daly AK (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353:717–719

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology and Toxicology, University Hospital Geneva, Micheli-du-Crest 24, 1205, Geneva, Switzerland

    François Girardin & Jules Desmeules

  2. Hemostasis Unit, Division of Angiology and Haemostasis, Department of Medicine, University Hospital Geneva, 1205, Geneva, Switzerland

    Michèle Siegenthaler & Philippe de Moerloose

Authors
  1. François Girardin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michèle Siegenthaler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe de Moerloose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jules Desmeules
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François Girardin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Girardin, F., Siegenthaler, M., de Moerloose, P. et al. Rofecoxib interaction with oral anticoagulant acenocoumarol. Eur J Clin Pharmacol 59, 489–490 (2003). https://doi.org/10.1007/s00228-003-0628-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-003-0628-9

Keywords

Search

Navigation